Oral Treatment for Sleeping Sickness Using Melarsoprol Cyclodextrin Complexes
Author Information
Author(s): Rodgers Jean, Jones Amy, Gibaud Stéphane, Bradley Barbara, McCabe Christopher, Barrett Michael P., Gettinby George, Kennedy Peter G. E.
Primary Institution: University of Glasgow
Hypothesis
Can melarsoprol cyclodextrin inclusion complexes be an effective oral treatment for human African trypanosomiasis?
Conclusion
Melarsoprol cyclodextrin complexes are effective in curing CNS-stage human African trypanosomiasis when administered orally.
Supporting Evidence
- Melarsoprol cyclodextrin complexes were orally effective and non-toxic in curing CNS-stage trypanosome infections in mice.
- Parasite load within the brain was significantly reduced following treatment.
- Restoration of blood-brain barrier integrity was observed after treatment.
Takeaway
Researchers found a new way to give a medicine for a serious disease that usually needs a painful injection, and it worked well in mice.
Methodology
The study used in vitro and in vivo methods to test the efficacy of melarsoprol cyclodextrin complexes in mice infected with T.b. brucei.
Limitations
The study was conducted in a murine model, and results may not directly translate to human patients.
Participant Demographics
Female CD-1 mice (20–30 g body weight) were used in the study.
Statistical Information
P-Value
p=0.019
Confidence Interval
95% confidence interval 0.213 g, 1.954 g
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website